Net Cash Provided by (Used in) Financing Activities of BIOCEPT INC from 31 Dec 2017 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOCEPT INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2017 to 31 Mar 2023.
  • BIOCEPT INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $162,000.
  • BIOCEPT INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,871,000, a 115% decline from 2021.
  • BIOCEPT INC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12,378,000, a 52% decline from 2020.
  • BIOCEPT INC annual Net Cash Provided by (Used in) Financing Activities for 2020 was $25,720,000, a 13% decline from 2019.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOCEPT INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $162,000 +$430,000 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q1 2022 $268,000 +$34,000 +11% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $302,000 -$17,791,153 -102% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q1 2020 $17,489,153 +$869,918 +5.2% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q1 2019 $16,619,235 +$3,863,332 +30% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q1 2018 $12,755,903 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1

BIOCEPT INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,871,000 -$14,249,000 -115% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023 2022 FY
2021 $12,378,000 -$13,342,000 -52% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $25,720,000 -$3,942,594 -13% 01 Jan 2020 31 Dec 2020 10-K 05 Apr 2022 2021 FY
2019 $29,662,594 +$5,885,361 +25% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $23,777,233 +$5,189,048 +28% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $18,588,185 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.